Bank of America’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$316K Sell
45,989
-10,146
-18% -$69.8K ﹤0.01% 5028
2025
Q1
$162K Sell
56,135
-35,731
-39% -$103K ﹤0.01% 5312
2024
Q4
$432K Sell
91,866
-8,049
-8% -$37.8K ﹤0.01% 4825
2024
Q3
$357K Buy
99,915
+30,029
+43% +$107K ﹤0.01% 4858
2024
Q2
$433K Buy
69,886
+8,233
+13% +$51K ﹤0.01% 4660
2024
Q1
$582K Sell
61,653
-125,819
-67% -$1.19M ﹤0.01% 4469
2023
Q4
$1.27M Buy
187,472
+48,428
+35% +$327K ﹤0.01% 3977
2023
Q3
$617K Buy
139,044
+6,806
+5% +$30.2K ﹤0.01% 4352
2023
Q2
$436K Buy
132,238
+89,868
+212% +$297K ﹤0.01% 4560
2023
Q1
$121K Sell
42,370
-15,263
-26% -$43.5K ﹤0.01% 5385
2022
Q4
$420K Buy
57,633
+27,815
+93% +$202K ﹤0.01% 4805
2022
Q3
$242K Sell
29,818
-73,849
-71% -$599K ﹤0.01% 5088
2022
Q2
$508K Buy
103,667
+88,836
+599% +$435K ﹤0.01% 4729
2022
Q1
$351K Sell
14,831
-13,133
-47% -$311K ﹤0.01% 5342
2021
Q4
$495K Buy
27,964
+20,496
+274% +$363K ﹤0.01% 5113
2021
Q3
$211K Sell
7,468
-2,809
-27% -$79.4K ﹤0.01% 5432
2021
Q2
$108K Buy
10,277
+5,272
+105% +$55.4K ﹤0.01% 5692
2021
Q1
$59K Sell
5,005
-11,967
-71% -$141K ﹤0.01% 5894
2020
Q4
$199K Buy
16,972
+13,305
+363% +$156K ﹤0.01% 4887
2020
Q3
$29K Sell
3,667
-12,665
-78% -$100K ﹤0.01% 5541
2020
Q2
$298K Buy
16,332
+818
+5% +$14.9K ﹤0.01% 4458
2020
Q1
$186K Buy
15,514
+13,665
+739% +$164K ﹤0.01% 4568
2019
Q4
$31K Sell
1,849
-1,321
-42% -$22.1K ﹤0.01% 5567
2019
Q3
$22K Buy
+3,170
New +$22K ﹤0.01% 5726